3 Pitfalls Posed By Over-The-Counter Drug Recalls

Law360, New York (November 1, 2013, 9:20 PM EDT) -- Recalls can be trickier for over-the-counter drug makers than their prescription-drug counterparts, as the companies face a wider, more complex distribution network and a more wary U.S. Food and Drug Administration. Here, experts detail the potential pitfalls and how to navigate them.

The FDA looks for the same things during an inspection whether a facility produces painkillers to dull headaches or intravenous drugs to fight cancer, experts said. But to conduct as successful an over-the-counter drug recall as possible, attorneys should keep in mind several of...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.